[Renal aspergilloma: retroperitoneoscopic resection as a minimally invasive organ preservation treatment option]
Related Experiment Video
Updated: May 2, 2026

Robot-Assisted Kidney Transplantation
Published on: July 19, 2021
C Wetterauer1, M Rieken, G Müller
1Urologische Universitätsklinik Basel-Liestal, Spitalstraße 21, 4031, Basel, Schweiz.
Abstract:
Aspergillus infections frequently affect immunocompromised patients and are associated with high mortality. We report the case of a renal aspergilloma in a bone marrow transplant recipient. Treatment is challenging and requires a combination of systemic antifungal therapy and surgery. In the present case, a minimally invasive retroperitoneoscopic resection of the aspergilloma was performed.
Insights
Aspergillus infections, a serious risk for immunocompromised individuals, can manifest as renal aspergilloma. This case highlights successful minimally invasive surgical resection combined with antifungal therapy for a bone marrow transplant recipient.
Area of Science:
- Nephrology
- Transplant Surgery
- Mycology
Background:
- Aspergillus infections pose a significant threat to immunocompromised patients, often leading to high mortality rates.
- Renal aspergilloma is a rare but serious fungal infection of the kidney.
Observation:
- A case of renal aspergilloma is presented in a patient who received a bone marrow transplant.
- The patient's immunocompromised status heightened the risk and complexity of the infection.
Findings:
- Treatment of renal aspergilloma is complex, typically necessitating a multimodal approach.
- This case successfully employed a minimally invasive retroperitoneoscopic resection of the aspergilloma.
Implications:
- Minimally invasive surgical techniques can be effective in managing renal aspergilloma in transplant recipients.
- Successful outcomes depend on the judicious combination of systemic antifungal agents and surgical intervention.
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Kidney Transplant I: Introduction

